Abbott and Dexcom settled all patent lawsuits related to continuous glucose monitors (CGMs). The two competitors, who lead ...

Insulet announces the launch of Omnipod 5 in five more countries in Europe, Italy, Denmark, Finland, Norway and Sweden.

Abbott and Dexcom settled all patent lawsuits related to continuous glucose monitors ... In March 2024, a jury found that Dexcom’s G6 glucose monitors infringed one of three of Abbott’s ...

In a report released yesterday, William Plovanic from Canaccord Genuity maintained a Buy rating on Dexcom (DXCM – Research Report), with a ...

Acton, Massachusetts-based Insulet touts Omnipod 5 as the number one insulin pump for new users in Europe. It remains the top ...

DexCom, Inc. DXCM is well-poised for growth in the coming quarters, backed by its strong product portfolio. A ...

During her time at CNET, Kim Wong-Shing loved demystifying the world of wellness to make it accessible to any reader. She was also passionate about exploring the intersections of health, history ...

Dexcom (DXCM) has received a new Buy rating, initiated by Wells Fargo analyst, Larry Biegelsen.Stay Ahead of the Market:Discover outperforming ...

Dexcom, Inc., the world leader in real-time Continuous Glucose Monitoring (CGM) for people with diabetes, recently announced the launch of the Dexcom G6 mobile app in Spanish, available for download ...

Dexcom is a developer and marketer of continuous glucose monitoring ... Its top products include the Dexcom G6 which provides real-time glucose monitoring, Dexcom G7 which is user-friendly ...